healthcare
Novartis Eyes More Bolt-On Acquisitions, CEO Says
FinanceRussia Opens Negligence Probe After Nine Babies Die in Same Siberian Hospital
Pfizer CEO Plans for Soaring Consumer Market for Obesity Drugs Akin to Viagra
Novo Nordisk Sees Pills Capturing Over Third of GLP-1 Obesity Market by 2030

UK's Smith & Nephew to Buy Integrity Orthopaedics for up to $450 Million
Date: January 12, 2026
Jan 12 (Reuters) - British medical products maker Smith & Nephew will buy U.S.-based Integrity Orthopaedics in a deal that could be valued at up to $450 million, the company said on Monday. The deal...

UK Grocers Begin to Feel Impact of Appetite-Suppressing Drugs
Date: January 9, 2026
By James Davey LONDON, Jan 9 (Reuters) - Britain’s major food retailers are beginning to feel the impact of a new trend as the surging popularity of appetite-suppressing drugs starts to reshape...
Amazon Pharmacy Starts Offering Novo Nordisk's Wegovy Weight-Loss Pill
Date: January 9, 2026
Jan 9 (Reuters) - Amazon Pharmacy said on Friday it now offers Novo Nordisk's Wegovy pill through insurance plans as well as through a cash-pay option. (Reporting by Sneha S K; Editing by Krishna...
Analysis- Drugmakers Brace for Europe Pricing Fight After Trump's US Price-Cut Deals
Date: January 8, 2026
By Michael Erman and Maggie Fick NEW YORK/LONDON, Jan 8 (Reuters) - Global drugmakers face a battle in 2026 to secure higher prices for their prescription medicines in Europe after agreeing to cut U.S...
Soccer-Former England Forward Keegan Diagnosed With Cancer
Date: January 7, 2026
Jan 7 (Reuters) - Former England forward and manager Kevin Keegan has been diagnosed with cancer, his old club Newcastle United said on Wednesday. "Kevin Keegan was recently admitted to hospital for...
GSK's Chronic Hepatitis B Therapy Shows Promise in Key Studies, Analysts Await Full Data
Date: January 7, 2026
LONDON, Jan 7 (Reuters) - GSK's experimental drug to treat chronic hepatitis B infection met the main goal in two closely watched studies, the drugmaker said on Wednesday, bringing the company a step...
